ID   N18TG2
AC   CVCL_2132
SY   N18Tg2; N18 tg 2
DR   BTO; BTO:0000933
DR   CLO; CLO_0007921
DR   CLDB; cl3620
DR   DSMZ; ACC-103
DR   DSMZCellDive; ACC-103
DR   ECACC; 08062523
DR   TOKU-E; 4020
DR   Wikidata; Q54907323
RX   PubMed=598387;
RX   PubMed=1150088;
CC   Doubling time: ~40 hours (DSMZ=ACC-103).
CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4724 ! C-1300 clone N18
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
RX   PubMed=598387; DOI=10.1016/0014-2964(77)90155-4;
RA   Heumann R., Stavrou D., Reiser G., Ocalan M., Hamprecht B.;
RT   "Tumorigenicity of neuroblastoma X glioma hybrid cells in nude mice
RT   and reintroduction of transplanted cells into culture.";
RL   Eur. J. Cancer 13:1417-1420(1977).
RX   PubMed=1150088;
RA   Minna J.D., Yavelow J., Coon H.G.;
RT   "Expression of phenotypes in hybrid somatic cells derived from the
RT   nervous system.";
RL   Genetics 79 Suppl. 1:373-383(1975).